Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / S&P BIOTECH
-
Total 13F shares
-
36,580,871
-
Share change
-
-10,437,229
-
Total reported value
-
$2,166,998,035
-
Put/Call ratio
-
139%
-
Price per share
-
$59.19
-
Number of holders
-
274
-
Value change
-
-$634,249,141
-
Number of buys
-
138
-
Number of sells
-
99
Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q4 2016
As of 31 Dec 2016,
SPDR SERIES TRUST - S&P BIOTECH (XBI) was held by
274 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,580,871 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, MORGAN STANLEY, CITIGROUP INC, BNP PARIBAS ARBITRAGE, SA, UBS Group AG, BANK OF AMERICA CORP /DE/, STATE OF WISCONSIN INVESTMENT BOARD, WELLS FARGO & COMPANY/MN, SUVRETTA CAPITAL MANAGEMENT, LLC, and JPMORGAN CHASE & CO.
This page lists
276
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.